Professional Documents
Culture Documents
Ginkgo Biloba
Ginkgo Biloba
Ginkgo Biloba
INTRODUCTION
• Gingko Biloba, known as Ginkgo, has been around for over 1000
years, making it the world’s oldest living tree species. It is known to
be originated in China. (Saper, 2021)
• Gingko trees consist of small branches with fan-shaped leaves that
are bright green in summer and turn a golden yellow in the fall, with
inedible seeds that can be poisonous. (Saper, 2021)
• It is one of the most studied herbal remedies in the world, with over
400 clinical trials performed looking for various medicinal properties
and clinical uses, largely in neurological functions. (Saper, 2021)
• Ginkgo is commonly available as an oral tablet, extract, capsule, or
tea.
• Standardized Ginkgo Biloba Extract (GBE) derived from dried leaves
of Ginkgo contains 6% terpenoids, 24% flavonoid glycosides, and 5-
10% organic acids. Meanwhile, flavonoids and terpenoids are
considered the pharmacologically active ingredient of GBE. (Saper,
2021)
Clinical Uses Of Ginkgo
• Cerebrovascular insufficiency
• Peripheral artery insufficiency
• Multi-infarct dementia
• Memory impairment in elderly
• Alzheimer’s disease
• Resistant depression
• Asthma
• Venous insufficiency
(Singh et al., 2019)
SIDE EFFECT OF GINKGO
• Some of the side effects of Ginkgo include
• Increase risk of bleeding
• Gastrointestinal upset
• Headache
• Skin reaction including blisters,
erythema, and itchiness with ingestion
of non-leave part
Saper, B. R. (2021). Clinical use of ginkgo biloba. UpToDate. Retrieved May 6, 2023, from
https://www-uptodate- com.proxy.library.stonybrook.edu/contents/clinical-use-of-
ginkgo- biloba?search=ginkgo%20biloba&source=search_result&selected
Title=1~51&usage_type=default&display_rank=1
Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia-Villa, G., & Perry, G. (2019).
Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other
neurological Disorders. Neurotherapeutics : the journal of the American Society for
Experimental NeuroTherapeutics, 16(3), 666–674. https://doi.org/10.1007/s13311-019-
00767-8